Miltenyi Biotec 技術與願景

Miltenyi Biotec 成立於 1989 年，基於 MACS® (Magnetic-activated cell sorting)磁珠細胞分離技術的發明。 從那時起，Miltenyi Biotec的技術解決方案為生物醫學科學的進步做出了重要貢獻。 如今，Miltenyi Biotec的 18,000 多種產品在為未來醫學鋪路方面發揮著至關重要的作用。 為客戶的工作流程提供全面的解決方案，從基礎研究轉化​​為臨床應用．

博克科技與Miltenyi Biotec整合技術涵蓋廣泛的應用：從細胞學研究(MACS, Medium, REA antibody)到組織處理(gentleMACS, dead cell remove, MACS)，延伸至近年單細胞及胞器基因定序(Nuclei extraction, mitochondria extraction)、高內涵成像(MACSima, Ultramicroscope)和細胞療法(GMP medium, CliniMACS Prodigy, CliniMACS Plus)的商業規模製造。

近年治療方法已經全然不同，從基於化學的藥物治療演變為基於細胞的方法，針對個別病徵、個別細胞的細胞治療儼然成為新的方向。Miltenyi Biotec提供全面的規劃從臨床細胞分選、GMP細胞培養生產、冷凍袋保存細胞，封閉式細胞培養完整解決方案，更提供了後續進行QC品質檢測的標準流程：標準化無背景螢光抗體染色方法學、流式細胞儀上機至結果分析全面自動化（如附圖使用 CliniMACS Prodigy 平台上的 CliniMACS Prodigy Tubing Set 520 在封閉系統中產生基因工程 T 細胞的完整過程）

產品分類

組織前處理：

• genlteMACS 單細胞組織解離系統
• Sample preparation 細胞前處理試劑
• 磁珠細胞分選：
• MACS磁珠細胞分選
• AutoMACS Neo 自動化細胞分選系統

重組抗體：

• REAfinity 親和力重組抗體
• REAlease 蛋白解離抗體
• REAdye_lease 螢光解離抗體

影像系統：

• MACSima 高內涵切片染色成像系統
• Ultramicroscope and tissue clear 層光螢光顯微鏡及組織透明化技術

細胞培養及GMP細胞陪養:

• Cytokine and medium 細胞激素及細胞培養夜
• GMP cell culture bag GMP細胞培養袋
• GMP cell culture GMP細胞培養試劑
• GMP CryoMACS Freezing bag 細胞冷凍袋
• 流式細胞儀及GMP流式細胞分選：
• MACS Quant family 自動化流式細胞儀
• MACS Quant Tyto GMP等級細胞分選儀

臨床細胞系統：

• CliniMACS Plus 臨床級細胞分選系統
• CliniMACS Prodigy 全自動封閉式細胞生產系統

Miltenyi Biotec introduction 

Miltenyi Biotec was founded in 1989 based on the invention of MACS® (Magnetic-activated cell sorting) magnetic bead cell separation technology. Since then, Miltenyi Biotec's technological solutions have made important contributions to the advancement of biomedical science. Today, Miltenyi Biotec's more than 18,000 products play a vital role in paving the way for the future of medicine. Providing comprehensive solutions for customers' workflows, from basic research to translation into clinical applications.

J&H Technology and Miltenyi Biotec covers a wide range of applications: from cellular research (MACS, Medium, REA antibody) to tissue dissociation (gentleMACS, dead cell remove, MACS), extending to single cell and organelle gene sequencing (Nuclei extraction, mitochondria extraction), high-content imaging (MACSima, Ultramicroscope) and cell therapy (GMP medium, CliniMACS Prodigy, CliniMACS Plus).

In recent years, treatment methods have been completely different, evolving from chemical-based drug treatments to cell-based methods. Cell therapy targeting individual symptoms and individual cells has become a new direction.

We want to advance science and medicine. I believe that with the right tools, biomedical scientists can conquer difficult diseases such as cancer, autoimmune diseases, and neurodegenerative diseases.